Targeting Collagen in Cancer Therapy: New Research Offers Insights

Strategic Insights -

Research from Fudan University in Shanghai, China, has shed new light on the role of collagen in cancer development and growth. The study, published in Cancer Pathogenesis and Therapy, reveals that collagen plays a crucial role in creating a three-dimensional framework that supports tumor growth and development. The researchers also found that collagen interacts with specific tumor cell receptors, influencing tumor cell signaling pathways and promoting cancer progression and drug resistance.

Key Takeaways:

  • Collagen contributes to the formation and stiffness of the extracellular matrix, providing a framework for solid tumor growth and development.
  • Collagen interacts with specific tumor cell receptors, influencing tumor cell signaling pathways and promoting cancer progression and drug resistance.
  • Understanding the immunosuppressive mechanisms of collagen in the tumor extracellular matrix has revealed novel therapeutic targets and opportunities.
  • Integrating collagen scores with traditional immunoscore-based immunotyping methods may enhance response prediction.
  • Research has identified recent therapeutic developments in collagen targeting and their clinical potential for enhancing anti-cancer immunity.
  • Jingjing Li, Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, and her colleagues have made significant contributions to understanding the role of collagen in cancer therapy.

Statistics:

  • A comprehensive review of collagen's immunoregulatory functions in the tumor extracellular matrix is provided in the study.
  • The study highlights the importance of understanding the immunosuppressive mechanisms of collagen in cancer therapy.
  • Recent therapeutic developments in collagen targeting show promise for enhancing anti-cancer immunity.
  • The research has identified novel therapeutic targets and opportunities for cancer therapy.

Sources:

  • Targeting collagen in "armored and cold" tumors: Overcoming barriers to cancer therapy. Cancer Pathogenesis and Therapy, 2025,3(5):383-391.
  • Elsevier
  • https://doi.org/10.1016/j.cpt.2024.11.001.